These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 30791663)

  • 1. Functional Mesoporous Silica Nanocomposites: Biomedical applications and Biosafety.
    Castillo RR; Vallet-Regí M
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized mesoporous silica particles for application in drug delivery system.
    Pang J; Luan Y; Yang X; Jiang Y; Zhao L; Zong Y; Li Z
    Mini Rev Med Chem; 2012 Jul; 12(8):775-88. PubMed ID: 22512562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y; Chen H; Shi J
    Adv Mater; 2013 Jun; 25(23):3144-76. PubMed ID: 23681931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
    Castillo RR; Baeza A; Vallet-Regí M
    Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSNs-Based Nanocomposite for Biofilm Imaging and NIR-Activated Chem/Photothermal/Photodynamic Combination Therapy.
    Dai X; Ma J; Chen N; Cai Y; He Y; Li X; Gao F
    ACS Appl Bio Mater; 2021 Mar; 4(3):2810-2820. PubMed ID: 35014320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-step synthesis of degradable T(1)-FeOOH functionalized hollow mesoporous silica nanocomposites from mesoporous silica spheres.
    Peng YK; Tseng YJ; Liu CL; Chou SW; Chen YW; Tsang SC; Chou PT
    Nanoscale; 2015 Feb; 7(6):2676-87. PubMed ID: 25581508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
    Croissant JG; Fatieiev Y; Almalik A; Khashab NM
    Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
    Slowing II; Vivero-Escoto JL; Wu CW; Lin VS
    Adv Drug Deliv Rev; 2008 Aug; 60(11):1278-1288. PubMed ID: 18514969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bionanocomposites based on mesoporous silica and alginate for enhanced drug delivery.
    de Lima HHC; Kupfer VL; Moisés MP; Guilherme MR; de C Rinaldi J; Felisbino SL; Rubira AF; Rinaldi AW
    Carbohydr Polym; 2018 Sep; 196():126-134. PubMed ID: 29891279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous Silica Nanoparticles: A Versatile Platform for Biomedical Applications.
    Jain P; Hassan N; Iqbal Z; Dilnawaz F
    Recent Pat Drug Deliv Formul; 2018; 12(4):228-237. PubMed ID: 30501606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wrapped stellate silica nanocomposites as biocompatible luminescent nanoplatforms assessed in vivo.
    Perton F; Harlepp S; Follain G; Parkhomenko K; Goetz JG; Bégin-Colin S; Mertz D
    J Colloid Interface Sci; 2019 Apr; 542():469-482. PubMed ID: 30772509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous silica nanoparticles in drug delivery and biomedical applications.
    Wang Y; Zhao Q; Han N; Bai L; Li J; Liu J; Che E; Hu L; Zhang Q; Jiang T; Wang S
    Nanomedicine; 2015 Feb; 11(2):313-27. PubMed ID: 25461284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective.
    Hosseinpour S; Walsh LJ; Xu C
    J Mater Chem B; 2020 Nov; 8(43):9863-9876. PubMed ID: 33047764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites.
    Yang H; Chen Y; Chen Z; Geng Y; Xie X; Shen X; Li T; Li S; Wu C; Liu Y
    Biomater Sci; 2017 May; 5(5):1001-1013. PubMed ID: 28327716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.